Cargando…
Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection
INTRODUCTION: Etravirine is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) specifically designed to suppress the replication of viruses resistant to the three currently approved NNRTIs efavirenz, nevirapine, and delavirdine. AIMS: To assess the evidence for the place of etravirine in...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899779/ https://www.ncbi.nlm.nih.gov/pubmed/20694071 |